Skip to main content
. 2015 Jul 3;5:11901. doi: 10.1038/srep11901

Figure 2. Percentage of patients with hepatic steatosis <5%, 5–33% and >33%, respectively, stratified by body mass index and PNPLA3 rs38409 genotype.

Figure 2

Supplementary Figure 1 Proportion of hepatic steatosis in patients with different PNPLA3 rs38409 genotypes, stratified by BMI.